-transparent.png){kind=logo}
Investigation of the antiinflammatory properties of bee venom demonstrates that it inhibits production of superoxide anion by human neutrophils in a potent, selective, nontoxic, dose-dependent fashion, both pre- and poststimulation by particulate and soluble activators of the neutrophil oxidative metabolism burst. The effect is not due to receptor competition, superoxide dismutase, and/or catalase activity, scavenging, or indicator media effects. These findings may explain the antiinflammatory effects of whole bee venom in experimental systems, its widespread use in folk medicine, and lead to the development of potent, new antiinflammatory substances for therapeutic use in man.
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
January 2006,
Antioxidants & redox signaling,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
April 1992,
Annals of the New York Academy of Sciences,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
April 1988,
Thrombosis and haemostasis,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
February 1998,
Biological & pharmaceutical bulletin,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
January 1989,
Free radical research communications,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
December 1983,
FEBS letters,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
January 1983,
Experientia,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
October 1985,
Life sciences,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
December 2000,
Infection and immunity,
S D Somerfield, and
J L Stach, and
C Mraz, and
F Gervais, and
E Skamene
January 1984,
Advances in experimental medicine and biology,
